Ischemic wounds of the lower extremity can fail to heal despite successful revascularization. The foot can be divided into six anatomic regions (angiosomes) fed by distinct source arteries arising from the posterior tibial (three), anterior tibial (one), and peroneal (two) arteries. This study investigated whether bypass to the artery directly feeding the ischemic angiosome had an impact on wound healing and limb salvage. Retrospective analysis was performed for 52 nonhealing lower extremity wounds (48 patients) requiring tibial bypass over a 2-year period. Preoperative arteriograms were reviewed to determine arterial anatomy relative to each wound's specific angiosome and bypass anatomy. Patients were divided into two groups; direct revascularization (DR, bypass to the artery directly feeding the ischemic angiosome) or indirect revascularization (IR, bypass unrelated to the ischemic angiosome). Wound outcome was analyzed with regard to the endpoints of complete healing, amputation, or death unrelated to the wound. Time to healing was also noted for healed wounds. Based on preoperative arteriography, 51% (n = 27) of the wounds received DR to the ischemic angiosome, while 49% (n = 25) underwent IR. There were no statistically significant differences in the comorbidities of the two groups. Revascularization was via tibial bypass using the saphenous vein (n = 34, 65%) or polytetrafluoroethylene with a distal vein patch (n = 18, 35%). Bypasses were performed to the anterior tibial (n = 22, 42%), posterior tibial (n = 17, 33%), or peroneal (n = 13, 25%) arteries based on the surgeon's judgment. One bypass failed in the perioperative period and was excluded from the analysis. The remaining bypasses were patent at the time of wound analysis. Due to a 17% mortality rate during follow-up, 43 wounds were available for endpoint analysis. This analysis demonstrated that 77% of wounds (n = 33) progressed to complete healing and 23% of wounds (n = 10) failed to heal with resultant amputation. In the DR group, there was 91% healing with a 9% amputation rate. In the IR group, there was 62% healing with a 38% amputation rate (p = 0.03). In those wounds that did heal, total time to healing was not significantly different--DR 162.4 days versus IR 159.8 days (p = 0.95). Revascularization plays a crucial role in the treatment of ischemic lower extremity wounds. We believe that direct revascularization of the angiosome specific to the anatomy of the wound leads to a higher rate of healing and limb salvage. Although many factors must be considered in choosing the target artery for revascularization, consideration should be given to revascularization of the artery directly feeding the ischemic angiosome.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.avsg.2008.08.022 | DOI Listing |
Khirurgiia (Mosk)
December 2024
Petrozavodsk State University, Petrozavodsk, Russia.
Objective: To evaluate the mid-term results of endovascular revascularization of the lower extremities through primary retrograde distal approach.
Material And Methods: We prospectively analyzed the mid-term results of 74 endovascular surgeries via primary retrograde distal approach in 69 patients with lower extremity ischemia. Mean age of patients was 68.
Ann Plast Surg
November 2024
From the Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital; Washington, DC.
Background: Among patients with critical limb ischemia and tissue loss, revascularization is an essential component for limb salvage. Local flaps of the foot and ankle remain a versatile tool in reconstructive limb salvage but is dependent on adequate arterial flow. In patients with arterial occlusive disease requiring revascularization, there is a lack of evidence in the current literature investigating on the necessity of direct arterial flow to the respective angiosome for local flaps reconstruction.
View Article and Find Full Text PDFInfrapopliteal endovascular interventions (EVT) strategies in diabetic patients are still in debate because the lesions are more likely to be diffuse with a different pattern of collateral arteries ranging from reduced to normal caliber. The aim of this all-comers study was to analyse the outcome of two different infrapopliteal EVT strategies (Group I: angiosome-based direct revascularization - DR vs. Group II: complete (direct + indirect) revascularization strategy - CR) in diabetic patients with chronic limb-threatening ischemia (CLTI) in 2 time-periods.
View Article and Find Full Text PDFAnn Vasc Surg
January 2025
Department of Angiology and Vascular Surgery, Centro Hospitalar Universitário de Santo, António, Porto, Portugal; School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
Background: Diabetes is strongly correlated with the development of critical limb ischemia, with a predilection for below-the-knee and below-the-ankle patterns of arterial disease. The angiosome concept, described as a potential framework for targeted revascularization in critical limb ischemia, has generated divergent opinions over the last decades. This study aims to evaluate the implication of angiosome-targeted revascularization in wound healing in diabetic patients.
View Article and Find Full Text PDFActa Diabetol
September 2024
Department of Systems Medicine, University of Rome "Tor Vergata", 00133, Rome, Italy.
Aim: The current study aimed to evaluate the effectiveness of peripheral blood mononuclear cells (PB-MNCs) therapy for patients with ischaemic diabetic foot ulcers (DFUs) treated through indirect revascularization.
Methods: The study is a prospective non-controlled observational study including patients with neuro-ischaemic DFUs who received indirect peripheral revascularization and showed a persistence of wound ischaemia defined by the absence of angiographic collateral vessels and TcPO2 values < 30 mmHg in the wound angiosome area. All patients received 3 cycles of PB-MNCs therapy administered along the wound related artery based on the angiosome theory.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!